Taste receptors (TASRs) and appetite and reward (AR) mechanisms influence eating behaviour, which in turn affects food intake and risk of obesity. In a previous study, we used next generation sequencing to identify potentially functional mutations in TASR and AR genes and found indications for genetic associations between identified variants and growth and fat deposition in a subgroup of animals (n = 38) from the UNIK resource pig population. This population was created for studying obesity and obesity-related diseases. In the present study we validated results from our previous study by investigating genetic associations between 24 selected single nucleotide variants in TASR and AR gene variants and 35 phenotypes describing obesity and metabolism in the entire UNIK population (n = 564). Fifteen variants showed significant association with specific obesity-related phenotypes after Bonferroni correction. Six of the 15 genes, namely SIM1, FOS, TAS2R4, TAS2R9, MCHR2 and LEPR, showed good correlation between known biological function and associated phenotype. We verified a genetic association between potentially functional variants in TASR/AR genes and growth/obesity and conclude that the combination of identification of potentially functional variants by next generation sequencing followed by targeted genotyping and association studies is a powerful and cost-effective approach for increasing the power of genetic association studies.
Introduction
Growth and obesity are partially regulated by a set of genes modulating the sense of taste and energy homeostasis. The perception of taste in the taste buds of the tongue is carried out mainly by taste receptors (TASRs). The selective activation of these receptors indicates whether a food is nutritious and safe. The set of TASRs includes two groups of G-protein coupled proteins, the TAS1Rs (TAS1R1, TAS1R2 and TAS1R3), which sense the palatable and energy-rich sweet and umami tastes produced by sugars and amino acids, and the TAS2Rs, including a large, diverse and highly polymorphic catalogue of genes that detect the bitter tastes associated with toxins and results in the rejection of potentially poisonous food (Breslin 2013) . In the gut, TASRs sense the ingested molecules and regulate the appetite and reward (AR) circuitries and, consequently, regulate eating behaviour, food transit time, digestion and nutrient absorption (Kiuchi et al. 2006; Loper et al. 2015) . The AR mechanisms involve the gastro-intestinal tract, pancreas, liver, brain, muscle and adipose tissues by engaging nutrients, neuropeptides, neurotransmitters, hormones and their related receptors and enzymes. These networks inhibit or excite the dopamine, epinephrine, norepinephrine, serotonin and glutamate receptor pathways and ultimately modulate food intake and energy balance (Fulton 2010; Loper et al. 2015) . These mechanisms, when unbalanced, can promote obesity, metabolic diseases and diabetes (Berg & Kaunitz 2016; Chao et al. 2016) . Hence, DNA polymorphisms altering the coding sequence of TASRs or AR genes could alter taste preferences and food intake with a resulting impact on energy balance, obesity and the outcome of diabetes or other metabolic disorders (Schembre et al. 2013; Clop et al. 2016) .
Pigs and humans share many anatomical, physiological, metabolic, genetic and patho-physiological similarities. For this reason, the pig is a highly relevant model in which to study human conditions like obesity (Koopmans & Schuurman 2015) . In the last decades the pig has been used extensively in biomedical research to investigate different aspects of obesity and its co-morbidities; from diet interventions studies using specific pig breeds (G€ ottingen Minipig, Ossabaw, production pigs) to more genetic-focused studies using custom-made pedigrees to gain basic knowledge about genes and pathways involved in obesity traits (Houpt et al. 1979; Andersson 1996; Pomp 1997; Spurlock & Gabler 2008) . Recently, an F2 resource population designed to elucidate the genetics involved in development of obesity and obesity-related phenotypes has been established: the UNIK population (Pant et al. 2015) . In this population, a total of 229 quantitative trait loci (QTL) associated with adiposity and metabolic phenotypes have been identified at genome-wide significance levels by genotyping single nucleotide polymorphisms (SNPs) on the Illumina 60K SNPchip and using a genome-wide linkage disequilibrium linkage analysis (LDLA) mapping approach.
Several studies have employed next generation sequencing methods to identify genetic variation in porcine TASR and AR genes. Two of these studies were aimed at the identification of differences in TASR genes between domestic and wild pig (da Silva et al. 2014; Clop et al. 2016; Ribani et al. 2017) . In these studies, more than 300 coding variants were found. The allele frequencies of 13 SNPs in five TASR genes were shown to be significantly different between two pools of Large White pigs grouped according to extreme and divergent estimated breeding values for backfat thickness and, thus, deemed to be associated with backfat thickness (Ribani et al. 2017) . Similarly, we previously conducted a study to identify variations in 10 TASR and 191 AR genes by targeted exome sequencing in more than 300 pigs from different breeds (Clop et al. 2016) . A total of 38 F2 UNIK animals selected for extreme values for daily weight gain and retroperitoneal fat content were included in this study, and nine variants in five TASR genes and 57 variants in 26 AR genes displayed significant differences in the predicted allele frequencies (pAFs) between the phenotypically divergent F2 pools indicating genetic association between these variants and growth and fat content (Clop et al. 2016) .
The aim of the present work was to further demonstrate in a large cohort the associations between some of the most pertinent variants in TASR and AR genes and obesityrelated traits that were discovered in our previous study. Thirty SNPs in TASR and AR genes that showed significant difference in pAF in the two phenotypically divergent F2 pools were selected and genotyped in the entire UNIK pedigree (n = 564), and the genetic associations between successfully genotyped SNPs and 35 phenotypes related to obesity and metabolism were evaluated.
Materials and methods

Animals used in the study
We previously established an F2 pig resource population specifically designed to investigate the genetic mechanisms involved in obesity by crossing the obesity prone G€ ottingen Minipig breed with two lean production pig breeds: Duroc and Yorkshire. This population has been described elsewhere (Kogelman et al. 2013) . Genotyping was performed in a total of 564 animals (23, 87 and 454 animals belonging to the parental, F1 and F2 generations respectively).
Phenotypes included in the association studies
Thirty-five different metabolic and physical obesity-related phenotypes were included in the association study (for a list of the phenotypes and their abbreviations see Table 1 ). The collection of phenotypes has been described elsewhere (Kogelman et al. 2013; Pant et al. 2015) . Blood samples were collected, and different phenotypes were measured at three time points: at about 2 months of age (63 AE 10 days = Age1), at approximately 7 months of age (218 AE 45 days = Age2) and at slaughter (242 AE 48 days = Age3). Concentrations of total cholesterol (CT), triglycerides (TG) and high density lipoprotein cholesterol (HDL-C) in plasma were determined using standard techniques. Low density lipoprotein cholesterol (LDL-C) levels were calculated using the Friedewald formula. Body composition was determined after weaning using dualenergy x-ray absorptiometry (DEXA) scanning at Age1. Plasma CETP (cholesteryl ester transfer protein) activity (CETP_per) was assayed using the method described by Guerin et al. (1994) .
Criteria for selection of SNPs for genotyping
Among the SNPs identified by Clop et al. (2016) , eight SNPs in TASR genes were selected based on their predicted impact on protein function according to SIFT and SNPEFF (Cingolani et al. 2012) . Additionally, among SNPs in AR genes, 22 SNPs that displayed significant differences in the pAFs between the phenotypically divergent sample pools in the study by Clop et al. (2016) were selected. Hence, 30 SNPs were selected for genotyping (see Table 2 ). It was ensured that all selected SNPs segregated at pAF of the minor allele at 0.08 or greater in the 38 UNIK animals that had been sequenced previously (Clop et al. 2016) , to maximize the probability of having all the genotypic classes represented in at least three animals in the whole F2 UNIK population (n = 564) and, thus, increase the power to detect genetic associations in the experiment.
Genotyping
The Fluidigm D3 ASSAY DESIGN online tool (https://d3.fluid igm.com) was used to design genotyping assays. SNP positions and 100 bp flanking the SNPs were submitted for assay design. SNP assays were run on a total of 564 animals using 96.96 IFC Dynamic Arrays and the SNPtype reagents Kit (Cat# BMK-M10-96.96GT-SNP), according to the manufacturer's recommendations. Samples with known genotypes were included as controls on each array. Of the 30 assays, 24 qualified for final analysis after excluding four assays that failed during the run and two SNPs that showed a minor allele frequency less than 5%.
Association analysis using PLINK
All phenotype data were checked for normality, and log or square root transformations were applied if required. SNP association analyses were performed using a mixed linear model in PLINK (Purcell et al. 2007 ). Cross and sex were fitted as fixed effects in all analyses. Additionally, age, age 2 and body length were included as covariates when appropriate (see Table 1 ). The PLINK option-adjust was used to calculate false discovery rate and Bonferroni corrected P-values.
Breed-specific allele frequencies
Alleles were counted for each SNP marker, and breedspecific allele frequencies were calculated based on allele count in purebred G€ ottingen Minipig, Duroc and Yorkshire founder animals (see Table S1 ).
Results and discussion
Association study
Out of 66 variants in TASR and AR genes that were identified previously by studying divergent F2 pools of animals from the UNIK population (Clop et al. 2016) , 24 SNPs located in eight TASR and 15 AR genes were successfully genotyped. Fifteen of these SNPs were significantly associated with at least one of 35 obesity-related phenotypes at a Bonferroni corrected significance level (P ≤ 0.05) ( Table 3 & Table S1 ). None of the TAS1R genes and only two TAS2R genes showed significant genetic associations: TAS2R9 with growth (DG2) and TAS2R4 with fat deposition (retro_fat) and blood lipid levels (CT_Age2, HDL-C_Age2). These results point to TAS2R4 as a common genetic determinator for both obesity and blood lipid levels. Thirteen variants in AR genes displayed significant genetic associations with at least one obesity-related phenotype.
The variant in ALDH3B2 was associated with both blood lipids (hdl_CF_Age1) and fat deposition (retro_fat) suggesting that this gene also is a common genetic determinator for these traits. The remaining 12 variants in AR genes had an effect on either growth/fat deposition or blood lipid traits. Variants in SIM1, ALDH1B1, P2RX7 and LEPR were associated with different measures of growth (DG1, DG2, ADG). For all these loci, the reference alleles, which also were the most frequent alleles in Duroc, had a positive effect on growth. Conversely, the alternative alleles with growthdecreasing effects in general had a high frequency in G€ ottingen Minipig and Yorkshire (i.e. except for one of the P2RX7 SNPs, for which both Duroc and Yorkshire were fixed for the reference allele). Variants in GRM1 and SIM1 were associated with fat deposition at Age1 measured by DEXA scanning (Tr_pfat, WB_pfat, WB_tf, WB_lean), whereas variants in P2RX7 were associated with subcutaneous fat deposition at Age3 (BF1). Other genes associated with blood lipid levels were FOS, MTNR1B and GPRC5C, i.e. the SNP in MTNR1B and in FOS showed association with the level of total and esterified cholesterol and phospholipids measured at young age (CE_Age1, CT_Age1, PL_Age1), whereas the SNP in GPRC5C displayed association with levels of low density lipoprotein cholesterol and total cholesterol measured at older age (LDL-C_Age2, CT_Age2). None of the significant genetic associations identified in the present study were recognised in a previous LDLA mapping study (Pant et al. 2015) . This demonstrates the power of association studies with genetic variants of potential phenotypic importance. A traditional genomewide association study, such as the LDLA previously performed in the UNIK pedigree (Pant et al. 2015) , can detect genetic associations only when a causal variant is in linkage disequilibrium (LD) with one or more of the genetic markers under analysis. However, if LD is weak, the QTL will remain undetected. The present work shows that this was the case in our previous LDLA. It should be noted that the same animals and phenotypes were used in both experiments. Even though different statistical models were applied, it is clear that none of the genetic associations found in the present study were reported using the 60K SNPchip (Table S1 ). As illustrated in Figs S1 & S2, this was not due to a lack of genetic markers in the previous association study. Instead, it was due to lack of robust LD between the coding variants tested now and the markers of the SNP chip.
It might be argued that the SNPs tested in the present study would not have been deemed genetically associated with a trait at a genome-wide significance level had they been included in a GWAS with a set of 60K markers. Although this is true, this mainly illustrates the limited power of the animal material (n = 564) and emphasizes that, especially for material with low power, it is highly beneficial to make an informed selection of markers to be included in the association study. The limitation of our approach is, of course, that only QTL in selected genes can be detected, leaving most of the genome unexplored.
Fifteen out of the 24 successfully genotyped variants were genetically associated with obesity-related physical or metabolic phenotypes. Additionally, one locus (HTR1B) was found to be associated with borderline significance with high density lipoprotein cholesterol at Age3 (data not shown). Hence, 15 (16 if including the borderline significant locus) of 20 associations from Clop et al. (2016) were confirmed to be associated with growth, obesity or obesity-related traits. Additionally, we identified an association between a variant in TAS2R9 with daily gain (DG2) that was not detected in the subset of pigs used by Clop et al. (2016) . In conclusion, according to the present and more powerful method, the analysis performed by Clop et al. (2016) , based on a subset of extreme animals selected from the UNIK population, reports three false positives (out of 20) and only one false negative. This clearly demonstrates the strength of an approach selecting individuals with extreme phenotypes. However, the present study also clearly demonstrates how the inclusion of more individuals and phenotypes has the power to dissect, define and reveal endophenotypes underlying complex multifactorial phenotypes like obesity and growth. For example, the variant studied in TAS2R4 is not associated with only average daily gain and retroperitoneal fat content, as described by Clop et al. (2016) . More precisely, this locus is associated with deposition of retroperitoneal fat and subcutaneous fat but not with weight of omental fat or intestinal fat (data not shown). Additionally, the same locus is associated with blood levels of HDL-cholesterol, triglycerides and CETP, though only in older animals, not in young pigs.
The biology behind the associations
Taste receptor and AR genes influence eating behaviour, affecting food intake and subsequently obesity status. In the present study, 13 SNPs in 12 AR genes and two SNPs in TASR genes showed statistically significant association with one or more obesity-relevant phenotypes. Of these, four AR genes (SIM1, FOS, MCHR2 and LEPR) and two TASR genes (TAS2R4 and TAS2R9) corroborate previous knowledge on biological function. Out of these six genes, the SNPs in FOS, TAS2R4 and TAS2R9 give rise to amino acid substitutions, which suggests a direct impact on the phenotype. Variants tested in the remaining genes (SIM1, MCHR2 and LEPR) are synonymous, which suggests a more subtle or regulatory effect or linkage disequilibrium with a nearby causative mutation. SIM1, single-minded homolog 1, is a transcription factor involved in regulation of energy homeostasis through the melanocortin 4 receptor (MC4R) signalling pathway (Xi et al. 2013) . Sim1 (À/À) mice develop hyperphagic early-onset obesity (Michaud et al. 2001) . In humans, haploinsufficiency of SIM1 has been found to cause severe early-onset obesity (Holder et al. 2000) . The association found between the SNP in SIM1 and daily gain (DG1) and total lean mass (WB_lean), both at young age, indicates that common variants in this gene may have more subtle effects relevant in common obesity.
FOS is a member of the AP-1 family of inducible transcription factors involved in cell proliferation and differentiation, and it also activates the synthesis of phospholipids (Pecchio et al. 2011) . In the present study, the variation in FOS was associated with phospholipid levels (PL_Age1) as well as with high density cholesterol level (HDL-C_Age1) and esterified cholesterol level in LDLdepleted plasma (hdl_CE_Age1), all in the young pig. The G€ ottingen Minipig variant causes an amino acid change from cysteine (nonpolar) to arginine (basic), which may have a significant impact on protein function.
The melanin-concentrating hormone receptor 2 (MCHR2) gene encodes for a G-protein coupled receptor expressed in the arcuate nucleus and the ventral medial nucleus regions of the brain. Both areas are involved in regulation of food intake (Sailer et al. 2001) . The gene is present in humans, some other primates and carnivores as well as in pigs but is not found in rodents (Hill et al. 2001; Sailer et al. 2001) . Even though MCHR2 is not expressed in rodents, a recent study showed that expression of human MCHR2 in transgenic mice protected against diet-induced obesity (Chee et al. 2014) . There are several studies in humans linking several polymorphisms in this gene to obesity (Gibson et al. 2004; Ghoussaini et al. 2007) . In the present study, the SNP in this gene was found to be significantly associated with fasting glucose levels. The fact that this gene is found in pig and not in rodents underpins that the pig provides a better model than do rodents for metabolic disturbances associated with glucose metabolism.
Leptin signalling is the main mechanism controling food intake and energy homeostasis in mammals in order to modulate body mass and body composition. Activation of leptin receptors induces modifications in the expression of several hypothalamic neuropeptide genes (i.e. POMC, NPY, AGRP) resulting in hypophagia and increased energy expenditure (Balthasar 2006; Robertson et al. 2008) . In mice and humans, polymorphisms in both leptin and leptin receptor genes have been widely studied in relation to obesity. In pigs, several leptin variants have been associated with growth, fatness, feed intake and body composition (Munoz et al. 2009; Ovilo et al. 2010) , linking obesity with this appetite-regulating mechanism. These results are in agreement with the association found in the present study that links the SNP in LEPR to average daily gain.
TAS2Rs, including TAS2R4 and TAS2R9, mediate nutrient assimilation and endocrine responses (Bachmanov & Beauchamp 2007) . Chemosensory signalling pathways involving these TAS2Rs have been implicated in gut hormone release affecting obesity and adipocyte metabolism in mice (Avau et al. 2015) . Additionally, TAS2R genes are differentially expressed in the gastrointestinal tract in response to a high fat diet in mice (Vegezzi et al. 2014) . The TAS2R4 SNP included in this study results in an amino acid substitution (isoleucine to phenylalanine) in a transmembrane domain. This variant is associated with CETP activity (CETP_per) and cholesterol levels in blood (HDLC_Age2, CT_Age2) . This is in agreement with a potential relationship with cholesterol metabolism suggested by Pydi et al. (2016) , who reported that TAS2R4 displays cholesterol sensitivity in its signalling function. The association of the SNP in TAS2R9 and average daily gain (DG2) is also interesting as it may link taste perception with glucose metabolism and henceforth the feeling of satiety. Our results are in agreement with the study by Dotson et al. (2008) , who showed that certain variants of TAS2R genes, including variants in TAS2R9, are associated with type 2 diabetes and influence glucose homeostasis. The SNP genotyped in TAS2R9 results in a missense mutation changing a methionine to isoleucine. A functionally compromised TAS2R9 receptor could impact glucose homeostasis, resulting in increase in daily gain, providing an important link between alimentary chemosensation and body growth disturbances that can result in obesity.
Five out of the remaing nine SNPs in AR genes (MTNR1,B ALDH2, GPR179, GPRC5C and ALDH3B2) that showed statistically significant association with obesity-relevant phenotypes give rise to amino acid substitutions that suggest a direct impact on the phenotype. Variants tested in the remaining genes (GRM1, ALDH1B1 and P2RX7) are synonymous which, as mentioned above, might suggest a regulatory effect or LD with a nearby causative mutation. To our knowledge, the biological function in the context of obesity-related traits for these eight genes has not been clearly demonstrated previously. Three of the genes belong to the aldehyde dehydrogenase family of proteins (ALDH1B1, ALDH2, ALDH3B2), whereas the remaining are receptors expressed mainly in the central nervous system. As shown in Table 3 , some of the genes seem to be involved in regulation of metabolism, whereas others are involved in fat deposition and daily gain, and in most cases the functional importance is clearly age specific.
Conclusions and perspectives
We have analysed associations of a total of 15 variants located in two TASR and 12 AR genes and verified a genetic association with specific obesity-related phenotypes that we discovered in our previous study. For six variants, the effects on the associated phenotype(s) immediately agree with the known function of the genes. These six variants are located in four AR genes (SIM1, FOS, MCHR2 and LEPR) and two TASR genes (TAS2R4 and TAS2R9). With regards to the remaining eight variants in AR genes (MTNR1B, ALDH2, GPR179, GPRC5C, ALDH3B2, GRM1, ALDH1B1 and P2RX7) this study provides novel insights of potential functional importance due to the unique associations with specific obesity-related phenotypes. Interestingly, most of the 15 statistically significant associations are age specific, indicating that the regulation of fat deposition, weight gain and metabolism differs between adolescents and older individuals. Additional studies need to be performed to provide more specific information on the molecular pathways affected by the gene variants investigated here.
We have employed a targeted approach using potentially functional SNPs, previously identified by next generation sequencing, in the present genetic association study. Using these variants we identified a significant number of genetic associations that were missed in a traditional association analysis based on SNP arrays (Pant et al. 2015) . Thus, this strategy proved to be a powerful and cost-effective approach for increasing the power of genetic association studies for complex traits.
From an animal breeding perspective, our results prompt a discussion on how results from this and similar studies may be used. The biology underlying selected traits has until now remained an unopened black box in animal breeding. Here, we identify functional variants in genes related to eating behaviour, showing a direct association with growth and leanness. Hence, this study discloses genetic variants that have been unknowingly targeted by selection in traditional breeding programs. We suggest that this knowledge may be exploited in precision animal breeding in the future. 
Supporting information
Additional supporting information may be found online in the supporting information tab for this article: Figure S1 Comparison of results from a previous LDLA study and the present association analysis. Open symbols represent results for SNP markers used in the LDLA study. Black symbols represent results for the variant in ALDH1B1 tested in the present study. Position on chromosome 1 (Sscrofa11.1 assembly) is on the X-axis; the negative logarithm (base 10) of the raw P-value is on the Y-axis. Figure S2 Comparison of results from a previous LDLA study and the present association analysis. Open symbols represent results for SNP markers used in the LDLA study. The black symbol represents the result for the variant in P2RX7, position 33289293 tested in the present study. Position on chromosome 14 (Sscrofa11.1 assembly) is on the X-axis; the negative logarithm (base 10) of the raw P-value is on the Y-axis. Table S1 Results overview.
